Clinical Trial Update: A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept [NA]

View source ↗

Summary

Early-stage research describing a non-invasive diagnostic approach using CCR2-targeted PET imaging to monitor fibrotic changes in myelofibrosis, including pre-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Parma | Conditions: Myelofibrosis (MF) | NA | Status: RECRUITING